(DBPK) db x-trackers SP500 2x - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0411078636

Leveraged, Inverse, Equity, Trading, ETF, Daily

Description: DBPK db x-trackers SP500 2x

The db x-trackers S&P 500 2x Inverse Daily UCITS 1C (DBPK) is a German-originated ETF that offers a leveraged inverse exposure to the S&P 500 index, aiming to deliver twice the daily inverse return of the underlying index. This product is designed for sophisticated traders and investors seeking to capitalize on short-term market movements.

From a technical standpoint, the current price action of DBPK indicates a stagnant trend, with the last price hovering around 0.21. The short-term moving averages (SMA20 and SMA50) suggest a slightly bearish outlook, as they are positioned above the current price. However, the ATR (0.01) translates to a relatively high volatility of 6.54%, implying potential trading opportunities for those looking to capitalize on short-term price swings.

Fundamentally, the AUM of 48.30M EUR indicates a relatively modest asset base, which may impact liquidity and trading costs. Nevertheless, being a UCITS-compliant ETF, DBPK is subject to stringent regulatory requirements, providing a certain level of investor protection.

Combining technical and fundamental insights, a forecast for DBPK can be derived. Assuming the S&P 500 index experiences a significant decline, DBPK is likely to rally, potentially breaking above its 52-week high of 0.32. Conversely, if the S&P 500 index surges, DBPK will likely decline further, potentially testing its 52-week low of 0.21. Given the current technical setup, a trading strategy could involve closely monitoring the S&P 500 index for signs of a significant move and adjusting DBPK positions accordingly. A potential trading range for DBPK could be between 0.18 and 0.35, based on historical volatility and the current technical configuration.

To maximize returns, traders should closely monitor the S&P 500 index and adjust their DBPK positions accordingly, taking into account the ETFs leveraged inverse nature and associated risks. A thorough risk management strategy, including stop-loss orders and position sizing, is essential to mitigate potential losses.

Additional Sources for DBPK ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DBPK ETF Overview

Market Cap in USD 57m
Category Trading - Leveraged/Inverse Equity
TER 0.70%
IPO / Inception 2010-03-18

DBPK ETF Ratings

Growth Rating -79.2
Fundamental -
Dividend Rating 0.0
Rel. Strength -34.1
Analysts -
Fair Price Momentum 0.14 EUR
Fair Price DCF -

DBPK Dividends

Currently no dividends paid

DBPK Growth Ratios

Growth Correlation 3m -97.7%
Growth Correlation 12m -48.1%
Growth Correlation 5y -84%
CAGR 5y -25.62%
CAGR/Max DD 5y -0.33
Sharpe Ratio 12m -1.75
Alpha -13.11
Beta -1.700
Volatility 21.74%
Current Volume 15790.5k
Average Volume 20d 2448.4k
Stop Loss 0.2 (5.3%)
What is the price of DBPK shares?
As of July 12, 2025, the stock is trading at EUR 0.19 with a total of 15,790,470 shares traded.
Over the past week, the price has changed by +1.14%, over one month by -9.63%, over three months by -32.13% and over the past year by -25.62%.
Is db x-trackers SP500 2x a good stock to buy?
No, based on ValueRay´s Analyses, db x-trackers SP500 2x (XETRA:DBPK) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -79.20 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBPK is around 0.14 EUR . This means that DBPK is currently overvalued and has a potential downside of -26.32%.
Is DBPK a buy, sell or hold?
db x-trackers SP500 2x has no consensus analysts rating.
What are the forecasts for DBPK share price target?
According to our own proprietary Forecast Model, DBPK db x-trackers SP500 2x will be worth about 0.2 in July 2026. The stock is currently trading at 0.19. This means that the stock has a potential downside of -21.05%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.2 -21.1%